These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mortality in patients with atrial fibrillation and heart failure. Fauchier L, Gorin L. J Am Coll Cardiol; 2010 Jan 12; 55(2):168; author reply 168-9. PubMed ID: 20117389 [No Abstract] [Full Text] [Related]
8. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation. McLeod CJ, Gersh BJ. Arch Intern Med; 2009 Nov 23; 169(21):2032-3; author reply 2033. PubMed ID: 19933968 [No Abstract] [Full Text] [Related]
9. Electrical and pharmacologic cardioversion for atrial fibrillation. Kim SS, Knight BP. Cardiol Clin; 2009 Feb 23; 27(1):95-107, ix. PubMed ID: 19111767 [Abstract] [Full Text] [Related]
10. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Philippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG, AFFIRM Investigators. Am J Cardiol; 2005 Sep 15; 96(6):815-21. PubMed ID: 16169368 [Abstract] [Full Text] [Related]
11. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM. Am J Cardiol; 2007 May 01; 99(9):1252-7. PubMed ID: 17478153 [Abstract] [Full Text] [Related]
12. International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists. Santas E, Miñana G, Gummel J, Farcasan R, Payá A, Heredia R, Bodí V, Mollar A, Bertomeu-González V, Chorro FJ, Sanchis J, Lupón J, Bayés Genís A, Núñez J. Rev Esp Cardiol (Engl Ed); 2019 Aug 01; 72(8):616-624. PubMed ID: 30201288 [Abstract] [Full Text] [Related]
13. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. Bernhardt P, Schmidt H, Hammerstingl C, Lüderitz B, Omran H. J Am Soc Echocardiogr; 2005 Sep 01; 18(9):919-24. PubMed ID: 16153514 [Abstract] [Full Text] [Related]
14. Ablation for atrial fibrillation in congestive heart failure. Crijns HI, Tieleman RG, Van Gelder IC. N Engl J Med; 2005 Mar 17; 352(11):1148-9; author reply 1148-9. PubMed ID: 15784670 [No Abstract] [Full Text] [Related]
15. Atrial fibrillation and atherothrombosis: the importance of anticoagulation. Escobar C, Barrios V. Am Heart J; 2009 May 17; 157(5):e27; author reply e29. PubMed ID: 19376295 [No Abstract] [Full Text] [Related]
16. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators. Am Heart J; 2005 Apr 17; 149(4):650-6. PubMed ID: 15990748 [Abstract] [Full Text] [Related]